All Stories

  1. safinamide in different populations

    Article • Advances in Therapy, December 2023, Springer Science + Business Media

    Dr Carlo Cattaneo

  2. The effects of safinamide according to gender in Chinese parkinsonian patients

    Article • Scientific Reports, November 2023, Springer Science + Business Media

    Dr Carlo Cattaneo

  3. Pain in Parkinson's Disease: Pathophysiology, Classification and Treatment

    Article • Journal of Integrative Neuroscience, September 2023, IMR Press

    Dr Carlo Cattaneo

  4. Pharmacokinetic and Safety Study of Single and Multiple Oral Doses of Safinamide in Healthy Chinese Volunteers

    Article • Clinical Pharmacology in Drug Development, June 2023, Wiley

    Dr Carlo Cattaneo

  5. Efficacy of Safinamide and Gender Differences During Routine Clinical Practice

    Article • Frontiers in Neurology, December 2021, Frontiers

    Dr Carlo Cattaneo

  6. Long-Term Efficacy of Safinamide on Symptoms Severity and Quality of Life in Fluctuating Parkinson’s Disease Patients

    Article • Journal of Parkinson s Disease, January 2020, IOS Press

    Dr Carlo Cattaneo

  7. Long-term Efficacy of Safinamide on Parkinson’s Disease Chronic Pain

    Article • Advances in Therapy, March 2018, Springer Science + Business Media

    Dr Carlo Cattaneo

  8. Safinamide effects on mood in Parkinson's Disease

    Article • Journal of Parkinson s Disease, November 2017, IOS Press

    Dr Carlo Cattaneo

  9. Effects of safinamide on chronic pain in Parkinsonian patients

    Article • Journal of Parkinson s Disease, February 2017, IOS Press

    Dr Carlo Cattaneo

  10. Population pharmacokinetic and pharmacodynamic analyses of safinamide in subjects with Parkinson's disease

    Article • Pharmacology Research & Perspectives, August 2016, Wiley

    Dr Carlo Cattaneo

  11. Safinamide effects on motor fluctuations and cardinal symptoms in Parkinsonian fluctuating patients

    Article • Journal of Parkinson s Disease, March 2016, IOS Press

    Dr Carlo Cattaneo

  12. Post-hoc analysis of safinamide studies as add-on therapy to levodopa in mid- to late-stage fluctuating Parkinson’s disease patients

    Article • Parkinsonism & Related Disorders, January 2016, Elsevier

    Dr Carlo Cattaneo

  13. Favourable effect of safinamide on mood over 2-year treatment of fluctuating Parkinson’s disease patients

    Article • Parkinsonism & Related Disorders, January 2016, Elsevier

    Dr Carlo Cattaneo

  14. Long-term efficacy of safinamide as add-on to levodopa in Parkinson’s disease fluctuating patients: results from a 2-year placebo-controlled trial

    Article • Journal of the Neurological Sciences, October 2015, Elsevier

    Dr Carlo Cattaneo

  15. Effects of safinamide on dyskinesia

    Article • Journal of Parkinson s Disease, September 2015, IOS Press

    Dr Carlo Cattaneo

  16. Symptom relief in Parkinson disease by safinamide

    Article • Neurology, October 2006, Wolters Kluwer Health

    Dr Carlo Cattaneo

  17. Improvement of motor function in early Parkinson disease by safinamide

    Article • Neurology, August 2004, Wolters Kluwer Health

    Dr Carlo Cattaneo

  18. Pressor Response to Intravenous Tyramine in Healthy Subjects After Safinamide, a Novel Neuroprotectant With Selective, Reversible Monoamine Oxidase B Inhibition

    Article • Clinical Neuropharmacology, July 2003, Wolters Kluwer Health

    Dr Carlo Cattaneo